MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ARMP has $69,800K in assets. $381,386K in debts. $4,754K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
64.43%
Quick Ratio
64.43%
Cash Ratio
51.52%
Debt to Asset Ratio
546.40%
Unit: Thousand (K) dollars
Assets Breakdown
    • Operating lease right-of-use ass...
    • In-process research and developm...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Convertible loan, non-current
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
4,754 8,688 14,756 4,328
Prepaid expenses and other current assets
1,145 1,508 1,415 1,024
Other receivables
47 472 759 2,168
Total current assets
5,946 10,668 16,930 7,520
Restricted cash
4,120 5,390 5,390 5,390
Property and equipment, net
11,780 12,194 12,560 12,657
Operating lease right-of-use asset
33,395 33,911 39,917 40,504
In-process research and development
10,256 10,256 10,256 10,256
Goodwill
3,490 3,490 3,490 3,490
Other assets
813 973 973 973
Total assets
69,800 76,882 89,516 80,790
Accounts payable and accrued liabilities
1,448 1,705 1,999 1,540
Accrued compensation
2,815 2,191 1,843 1,584
Convertible loan, current
--48,088 33,445
Term debt, current
--82,992 78,891
Current portion of operating lease liabilities
4,593 4,564 4,525 4,488
Other current liabilities
372 487 503 137
Total current liabilities
9,228 8,947 139,950 120,085
Convertible loan, non-current
254,922 153,860 --
Term debt, non-current
87,976 103,061 15,240 -
Operating lease liabilities, net of current portion
26,183 26,533 26,837 27,131
Deferred tax liability
3,077 3,077 3,077 3,077
Total liabilities
381,386 295,478 185,104 150,293
Common stock, 0.01 par value 217,000,000 shares authorized 36,644,703 and 36,431,444 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
366 364 362 362
Additional paid-in capital
304,928 282,574 281,286 280,696
Accumulated deficit
-616,880 -501,534 -377,236 -350,561
Total stockholders' deficit
-311,586 -218,596 -95,588 -69,503
Total liabilities and stockholders' deficit
69,800 76,882 89,516 80,790
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$4,754K Prepaid expenses andother current assets$1,145K Other receivables$47K Operating leaseright-of-use asset$33,395K Property and equipment,net$11,780K In-process research anddevelopment$10,256K Total current assets$5,946K Restricted cash$4,120K Goodwill$3,490K Other assets$813K Total assets$69,800K Accumulated deficit-$616,880K Total liabilities andstockholders' deficit$69,800K Total stockholders'deficit-$311,586K Additional paid-in capital$304,928K Common stock, 0.01 parvalue 217,000,000...$366K Total liabilities$381,386K Convertible loan,non-current$254,922K Term debt,non-current$87,976K Operating leaseliabilities, net of current...$26,183K Total currentliabilities$9,228K Deferred tax liability$3,077K Current portion ofoperating lease...$4,593K Accrued compensation$2,815K Accounts payable andaccrued liabilities$1,448K Other currentliabilities$372K

Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals, Inc. (ARMP)